Nanobiotix is a nanomedicine company developing novel therapeutics for the local treatment of cancer.
Description
Nanobiotix SA develops nanomedicine programs for the treatment of cancer. The company provides NanoXray that offers a solution for cancer therapy based on a technology that is designed to allow destruction of cancer cells by inert particles. Its products include magnetic particles and laser activated nanoparticles for the treatment and diagnostic of cancer.
Last funding
Blurry Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Paris, Ile-de-France, France, Europe
Founded on
January 1, 2003
Exited on
December 10, 2020
Went public on
December 10, 2020
Stock symbol
NBTX
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$34056 - 789030
Sign in for full access
Investors
Noaccess, No Way, Uh Ohhhh, No Way, Absolutely Noaccess, Noaccess, Cannot Access, Noway Youcantaccess, Cannot Access